Search research articles
Contact Us
Filters
Showing results (11-20 of 93) with videos related to
Page
of 10
Sort By:
Reproductive Toxicology (Elmsford, N.Y.)
|
April 9, 2008
Trastuzumb exposure during pregnancy
Corinna Weber-Schoendorfer, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)
|
January 26, 2016
Pregnancy outcome after tocilizumab therapy in early pregnancy-a case series from the German Embryotox Pharmacovigilance Center
Corinna Weber-Schoendorfer, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)
|
June 28, 2005
Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS
Christof Schaefer, Doreen Hannemann, Reinhard Meister
Reproductive Toxicology (Elmsford, N.Y.)
|
December 5, 2016
Who seeks Teratology Information Service's advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy
Evelin Beck, Anna Lechner, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)
|
June 29, 2016
Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database
Katarina Dathe, Evelin Beck, Christof Schaefer
Archives of Women'S Mental Health
|
March 24, 2018
Paliperidone and pregnancy-an evaluation of the German Embryotox database
Marlies Onken, Inge Mick, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)
|
April 2, 2015
Hip arthroplasty with high chromium and cobalt blood levels--Case report of a patient followed during pregnancy and lactation period
Marc Oppermann, Cornelia Borisch, Christof Schaefer
Clinical Orthopaedics and Related Research
|
June 14, 2012
Case report: High chromium and cobalt levels in a pregnant patient with bilateral metal-on-metal hip arthroplasties
Juliane Fritzsche, Cornelia Borisch, Christof Schaefer
Archives of Gynecology and Obstetrics
|
May 16, 2009
Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy
Christof Schaefer, Reinhard Meister, Corinna Weber-Schoendorfer
Pharmaceuticals (Basel, Switzerland)
|
January 8, 2025
Do Major Pharmacovigilance Databases Support Evidence of Second Trimester NSAID and Third Trimester Paracetamol Fetotoxicity?
Katarina Dathe, Carolin Benndorf, Simone Bergner, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 93) with videos related to
Sort By:
Page
of 10
Reproductive Toxicology (Elmsford, N.Y.)
|
April 9, 2008
Trastuzumb exposure during pregnancy
Corinna Weber-Schoendorfer, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)
|
January 26, 2016
Pregnancy outcome after tocilizumab therapy in early pregnancy-a case series from the German Embryotox Pharmacovigilance Center
Corinna Weber-Schoendorfer, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)
|
June 28, 2005
Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS
Christof Schaefer, Doreen Hannemann, Reinhard Meister
Reproductive Toxicology (Elmsford, N.Y.)
|
December 5, 2016
Who seeks Teratology Information Service's advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy
Evelin Beck, Anna Lechner, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)
|
June 29, 2016
Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database
Katarina Dathe, Evelin Beck, Christof Schaefer
Archives of Women'S Mental Health
|
March 24, 2018
Paliperidone and pregnancy-an evaluation of the German Embryotox database
Marlies Onken, Inge Mick, Christof Schaefer
Reproductive Toxicology (Elmsford, N.Y.)
|
April 2, 2015
Hip arthroplasty with high chromium and cobalt blood levels--Case report of a patient followed during pregnancy and lactation period
Marc Oppermann, Cornelia Borisch, Christof Schaefer
Clinical Orthopaedics and Related Research
|
June 14, 2012
Case report: High chromium and cobalt levels in a pregnant patient with bilateral metal-on-metal hip arthroplasties
Juliane Fritzsche, Cornelia Borisch, Christof Schaefer
Archives of Gynecology and Obstetrics
|
May 16, 2009
Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy
Christof Schaefer, Reinhard Meister, Corinna Weber-Schoendorfer
Pharmaceuticals (Basel, Switzerland)
|
January 8, 2025
Do Major Pharmacovigilance Databases Support Evidence of Second Trimester NSAID and Third Trimester Paracetamol Fetotoxicity?
Katarina Dathe, Carolin Benndorf, Simone Bergner, et al.
Page
of 10